Activation of HIF-1α C-terminal Transactivation Domain Protects Against Hypoxia-Induced Kidney Injury Through Hexokinase 2-Mediated Mitophagy

Zuo-Lin Li,Lin Ding,Rui-Xia Ma,Yue Zhang,Yi-Lin Zhang,Wei-Jie Ni,Tao-Tao Tang,Gui-Hua Wang,Bin Wang,Lin-Li Lv,Qiu-Li Wu,Yi Wen,Bi-Cheng Liu

DOI: https://doi.org/10.1038/s41419-023-05854-5

2023-01-01

Cell Death and Disease

Abstract:The transcription factor hypoxia-inducible factor-1α (HIF-1α), as a master regulator of adaptive responses to hypoxia, possesses two transcriptional activation domains [TAD, N-terminal (NTAD), and C-terminal (CTAD)]. Although the roles of HIF-1α NTAD in kidney diseases have been recognized, the exact effects of HIF-1α CTAD in kidney diseases are poorly understood. Here, two independent mouse models of hypoxia-induced kidney injury were established using HIF-1α CTAD knockout (HIF-1α CTAD −/− ) mice. Furthermore, hexokinase 2 (HK2) and mitophagy pathway are modulated using genetic and pharmacological methods, respectively. We demonstrated that HIF-1α CTAD −/− aggravated kidney injury in two independent mouse models of hypoxia-induced kidney injury, including ischemia/reperfusion-induced kidney injury and unilateral ureteral obstruction-induced nephropathy. Mechanistically, we found that HIF-1α CTAD could transcriptionally regulate HK2 and subsequently ameliorate hypoxia-induced tubule injury. Furthermore, it was found that HK2 deficiency contributed to severe renal injury through mitophagy inhibition, while mitophagy activation using urolithin A could significantly protect against hypoxia-induced kidney injury in HIF-1α C-TAD −/− mice. Our findings suggested that the HIF-1α CTAD-HK2 pathway represents a novel mechanism of kidney response to hypoxia, which provides a promising therapeutic strategy for hypoxia-induced kidney injury.